why choose us

Clinical Trials Search

Showing 8,660 of 132,963 result(s)
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

Status: Completed

Condition: Lung Cancer

Interventions: Delivered by a nurse or other healthcare provider, includes 2 in-person sessions, and phone check-ins, and occurs primarily during infusion visits.

Date: 2023-09-14

A Study of CT-868 in Type 1 Diabetes Mellitus

Status: Completed

Condition: Overweight

Interventions: CT-868 is an investigational medication administered subcutaneously via a pre-filled pen injector device.

Date: 2023-09-14

Daratumumab for Polyneuropathy Associated With MGUS

Status: Completed

Condition: Peripheral Neuropathy

Interventions: subucatneous, fixed dose 1800mg combination drug product containing rHuPH20 drug substance (2000 U;mL) and daratumumab drug substance (120 mg

Date: 2023-09-14

Transcutaneous Auricular Neurostimulation After Lumbar Fusion Surgery

Status: NOT_YET_RECRUITING

Condition: Pain, Postoperative

Interventions: This method of simultaneous vagal and trigeminal stimulation via the external ear is known as transcutaneous auricular neurostimulation (tAN), as the

Date: 2023-09-14

Assessment of Measurement Variability Across Automated Biometry Devices

Status: Completed

Condition: Myopia

Interventions: Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

Date: 2023-09-14

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

Status: NOT_YET_RECRUITING

Condition: Chronic Graft Versus Host Disease

Interventions: 200mg PO QD x 24 cycles (28-day cycle)

Date: 2023-09-14

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R;M) HPV Negative Head and Neck Squamous Cell Carcinoma

Status: Completed

Condition: Metastatic Head-and-neck Squamous-cell Carcinoma

Interventions: Ficlatuzumab (AV-299) is a humanized hepatocyte growth factor (HGF) inhibitory immunoglobulin G1 (IgG1) monoclonal antibody (mAb).

Date: 2023-09-14

Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI;US Image Fusion for Guidance

Status: Completed

Condition: Prostate Cancer

Interventions: Removal of cancerous tissue through the direct application of laser energy

Date: 2023-09-14

RCT of Intensive Multi-Couple Therapy for PTSD Versus Relationship Education in Military Couples

Status: Completed

Condition: Posttraumatic Stress Disorder

Interventions: Approximately 12 hours of programming delivered over 2 consecutive days in a multi-couple group retreat format.
Couples are provided with psychoe

Date: 2023-09-14